MIGENIX First Fiscal Quarter 2007 Financial Results Conference Call & Web Cast Notification
September 14, 2006
VANCOUVER, BC, and SAN DIEGO, CA, Sept. 14 /CNW/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, will host a conference call and web cast on Friday, September 15th, 2006 at 10:30 a.m. ET (7:30 a.m. PT) to discuss financial results for the first fiscal quarter ended July 31, 2006. An update on company activities will also be provided. To participate in the conference call, please dial 416-644-3423 or 1-866-250-4910. The call will be available for replay until October 3rd, 2006 by calling 416-640-1917 or 1-877-289-8525 and entering the pass code 21202134 followed by the number sign. The live and archived web cast can be accessed through the company's website at www.migenix.com for the next 90 days.
About MIGENIX
MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I) and the treatment of dermatological diseases (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information canbe found at www.migenix.com.
For further information:
Art Ayres, MIGENIX Inc.
Tel: (604) 221-9666 Extension 233
aayres@migenix.com
Dian Griesel, Ph.D.
Investor Relations Group
Tel: (212) 825-3210
Theproteam@aol.com
